Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

説明

<jats:p>Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological progression in the emerging field of mechanomedicine.</jats:p>

収録刊行物

  • Science Translational Medicine

    Science Translational Medicine 10 (422), eaao0475-, 2018-01-03

    American Association for the Advancement of Science (AAAS)

被引用文献 (5)*注記

もっと見る

問題の指摘

ページトップへ